The decision follows ongoing investigations into serious adverse events primarily reported in elderly individuals who ...

Leandro Boer, MD, PhD, VP, US general medicines, Amgen, discusses new real-world data showing that most high-risk ...

What was once considered a competitive advantage for forward-thinking commercial teams has now become essential for success ...

The Hardest Job in Biopharma? The Vice President of Market Access ...